Results

Total Results: 839 records

Showing results for "phase".

  1. effectivehealthcare.ahrq.gov/sites/default/files/manges.pdf
    May 29, 2025 - ENVIRONMENTAL PROTECTION AGENCY INNOVATIONS CONFERENCE -- ENVIRONMENTAL PROTECTION AGENCY SPEAKER: ELLEN MANGES, SENIOR ADVISOR, OFFICE OF SOLID WASTE AND EMERGENCY RESPONSE (OSWER) ENVIRONMENTAL PROTECTION AGENCY (EPA) MANGES: My name is Ellen Manges. I'm a senior advisor. I…
  2. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists the three topics for which (1) preliminary phase III or bioequivalence … Two late-phase multicenter trials are ongoing, and we continue to track this topic.
  3. effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists the three topics for which (1) preliminary phase III data for drugs were … The Horizon Scanning System is tracking several drugs in late-phase development.
  4. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists two topics for which preliminary phase III data were available for a drug … The 6-month buprenorphine implant completed phase III trials, one of which was funded by the National
  5. effectivehealthcare.ahrq.gov/sites/default/files/12_pregnancy_potential_high_impact_2012-12-11.pdf
    January 01, 2012 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in phase … Results The table below lists the three topics for which (1) preliminary phase III data were available … for drugs, phase II or III data were available for devices and procedures, or some human data were
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/prevent-hai-protocol.pdf
    April 16, 2024 - ,ab) #15 RCTs ('random sample'/de OR 'randomization'/de OR 'randomized controlled trial'/exp OR 'phase … 3':ti,ab OR 'phase iii':ti,ab OR random*:ti,ab OR RCT:ti,ab) #16 Observational/ Cohort Studies/
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ocr-protocol-final_1.pdf
    December 18, 2019 - dilation for fetal distress • Cervical assessment at time of admission (e.g., latent vs. active phase … dilation for fetal distress • Cervical assessment at time of admission (e.g., latent vs. active phase … dilation for fetal distress • Cervical assessment at time of admission (e.g., latent vs. active phase … dilation for fetal distress • Cervical assessment at time of admission (e.g., latent vs. active phase
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
    March 01, 2013 - Trospium chloride improves overactive bladder symptoms: a multicenter phase III trial. … Efficacy and safety of solifenacin succinate 10 mg once Daily: A multicenter, phase III, randomized … Multicenter phase III trial studying trospium chloride in patients with overactive bladder. … A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety … Trospium chloride improves overactive bladder symptoms: a multicenter phase III trial.
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/traumatic-brain-injury-rehabilitation-surveillance-160902.pdf
    May 29, 2025 - $$$randomized$controlled$trial/$(416302)$ 11$$$$$clinical$trial/$(500056)$ 12$$$$$clinical$trial,$phase … $i.pt.$(16112)$ 13$$$$$clinical$trial,$phase$ii.pt.$(26010)$ 14$$$$$clinical$trial,$phase$iii.pt.$( … 11141)$ 15$$$$$clinical$trial,$phase$iv.pt.$(1169)$ 16$$$$$controlled$clinical$trial.pt.$(90707)$ … $Electromyogram"lengthening$velocity$relation$in$ plantar$flexors$during$stance$phase$of$gait$in$patients … $The$Relationship$of$Health$Locus$ of$Control$and$Health"Related$Quality$of$Life$in$the$Chronic$Phase
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_surveillance.pdf
    April 01, 2012 - AHRQ Comparative Effectiveness Review Surveillance Program CER #32: Diagnosis and Treatment of Obstructive Sleep Apnea in Adults Original release date: August 8, 2011 Surveillance Report: July, 2012 Key Findings: - The conclusions for KQ2 (phased testing), KQ3 (preoperative screening), KQ6 (compliance…
  11. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_executive.pdf
    December 01, 2011 - (i.e., dye is strongly persistent after three cardiac cycles of the washout phase and either does not … that clears normally and is either gone or only mildly/moderately persistent at the end of the washout phase … (i.e., dye is gone or is mildly/moderately persistent after three cardiac cycles of the washout phase … and noticeably diminishes in intensity during the washout phase), similar to that in an uninvolved artery … Blush that is of only mild intensity throughout the washout phase but fades minimally is also classified
  12. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists the four topics for which (1) preliminary phase III data for drugs and … biologics or phase II data for devices and procedures were available; (2) information was compiled … Phase III trials reported that patients with SBS treated with teduglutide can significantly reduce … day), once daily.65 Clinical trials: In results of a randomized, double-blind, placebo-controlled, phase
  13. effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists a single topic for which (1) preliminary phase III data were available … study of oxytocin for treating ASDs using the company’s OptiNose nasal drug delivery technology; a phase
  14. effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1406.pdf
    February 01, 2015 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists the one topic for which (1) preliminary late-phase clinical trial data … The latter group is lead sponsor on the largest ongoing trial, a phase II/III trial investigating intranasal
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-221-copd-comments_0.pdf
    October 11, 2019 - interventions, such as community care after hospital discharge, and we focused on the most acute phase … systematic review did not include health services interventions, and we focused on the initial most acute phase … rehabilitation commenced before hospital discharge and that during ECOPD refers to the initial most acute phase … body vibration commenced before hospital discharge and that during ECOPD refers to the most acute phase
  16. effectivehealthcare.ahrq.gov/sites/default/files/study-eligibility-criteria.ppt
    January 01, 2000 - beginning abstract review Selecting Criteria Broader criteria are often set at the abstract review phase … and refined to be more specific for the full-text review phase, so this process is likely to occur twice
  17. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists the three topics for which (1) preliminary phase III data for drugs (or … preliminary late-phase clinical trial data for off-label drug indications) was available; (2) information … A phase II/III trial enrolling patients with MDD (n=40) found that intravenous scopolamine, administered
  18. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/telehealth-during-COVID-19-amendments.pdf
    April 28, 2022 - Each of these considerations had been discussed with the stakeholders during the topic refinement phase … : the era of COVID-19 (March 2020-present) KQ1d: During the first 4 months or beyond the initial phase … the era of COVID-19 (March 2020-present) KQ1d: During the first 4 months or beyond the initial phase … 20 Appendix A: Cost Outcomes Infrastructure Cost of implementation and sustaining phase
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/anal-cancer-protocol.pdf
    September 26, 2023 - The Key Questions (KQs) The KQs were posted online for public comments during the pre-award phase and … chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase … maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/liver-cancer_research-protocol.pdf
    July 24, 2013 - The diagnosis phase involves the use of additional tests (radiological and/or histopathological) to … technology is currently in use or not, and the technical aspects of each technology (such as row number, phase

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: